Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis

Author： Angeles-Han Sheila T   Yeh Steven   Vogler Larry B  

Publisher： Future Medicine

ISSN： 1758-4272

Source： International Journal of Clinical Rheumatology, Vol.8, Iss.1, 2013-02, pp. : 109-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis

By Molina Clara   Modesto Consuelo   Martín-Begué Nieves   Arnal Cristina  

Clinical Rheumatology, Vol. 32, Iss. 11, 2013-11 ,pp. : 1673-1675

Springer Publishing Company

Access to resources Recommend Favorite

Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland?

By Immonen K.   Savolainen H. A.   Hakala M.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 5, 2007-01 ,pp. : 402-403

Informa Healthcare

Access to resources Recommend Favorite

New developments in the management of juvenile idiopathic arthritis-related uveitis

By Zannin Maria Elisabetta   Zulian Francesco  

Future Rheumatology, Vol. 3, Iss. 6, 2008-12 ,pp. : 587-598

Future Medicine

Access to resources Recommend Favorite

Leflunomide in juvenile idiopathic arthritis

By Silverman Earl   Strand Vibeke  

Future Rheumatology, Vol. 1, Iss. 6, 2006-12 ,pp. : 673-682

Future Medicine

Access to resources Recommend Favorite

Outcome in adults with juvenile idiopathic arthritis

By Bruinooge L.N.   Moussaoui R. El   Taal E.   Dijkmans B.A.C.   Van Soesbergen R.M.  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 2, 2003-01 ,pp. : 89-94

Informa Healthcare

Access to resources Recommend Favorite